Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies

Inclusion Criteria: * Dyad consists of a pediatric patient aged 2-17 years undergoing myelosuppressive therapies for acute leukemias and other childhood cancers. * Dyad also includes a caregiver, ≥ 18 years of age that is willing to participate in the study. * Ability of caregiver or patient (if old enough) to read and speak English. * If applicable, willingness of the patient to shave axillary (armpit) hair. * Caregiver (parent or legal guardian) must give informed consent for dyad participation. Exclusion Criteria: * Patient has a history of allergy to hydrogel dressing or ongoing skin diseases * Patients with ongoing febrile illness or documented infectious disease.